Publications by authors named "Richard Nicoletti"

Claim this Profile
G
Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss.
Lorena Lerner, Jeno Gyuris, Richard Nicoletti, James Gifford, Brian Krieger

Oncol Lett· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAP3K11/GDF15 axis is a critical driver of cancer cachexia.
Lorena Lerner, Julie Tao, Qing Liu, Richard Nicoletti, Bin Feng

J Cachexia Sarcopenia Muscle· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients.
Lorena Lerner, Teresa G Hayes, Nianjun Tao, Brian Krieger, Bin Feng, Richard Nicoletti

J Cachexia Sarcopenia Muscle· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
23814, an Inhibitory Antibody of Ligand-Mediated Notch1 Activation, Modulates Angiogenesis and Inhibits Tumor Growth without Gastrointestinal Toxicity.
Theresa Proia, Feng Jiang, Alisa Bell, Richard Nicoletti, Lingxin Kong

Mol Cancer Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor models.
Kristan Meetze, Sylvie Vincent, Steven Tyler, Elizabeth K Mazsa, Andrea R Delpero, Richard Nicoletti

Clin Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy.
Jordi Barretina, Barry S Taylor, Shantanu Banerji, Alexis H Ramos, Mariana Lagos-Quintana, Richard Nicoletti

Nat Genet· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-sensitive FGFR2 mutations in endometrial carcinoma.
Amit Dutt, Helga B Salvesen, Tzu-Hsiu Chen, Alex H Ramos, Robert C Onofrio, Richard Nicoletti

Proc Natl Acad Sci U S A· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis